14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
1
Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.

Biota Scientific Management
1
Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents.

St. John'S University
1
Inhibitory effect of novel somatostatin peptide analogues on human cancer cell growth based on the selective inhibition of DNA polymeraseß.

Kobe Gakuin University
5
Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase.

Max Delbruck Center
3
1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.

Tibotec
4
GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.

Gilead Sciences
4
PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.

Pharmasset
2
Novel azaphilones, kasanosins A and B, which are specific inhibitors of eukaryotic DNA polymerases beta and lambda from Talaromyces sp.

Tokyo University of Science
23
Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023.

Shanghai University
6
Synthetic approaches and application of clinically approved small-molecule drugs to treat hepatitis.

Children's Hospital Affiliated to Zhengzhou University
49
Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109.

Central Pharmaceutical Research Institute
47
Identification of

Repare Therapeutics
2
Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.

The University of Texas
17
Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors.

Novo Nordisk